Link to this page
Myocardial Infarction Ontology
Last uploaded:
December 18, 2024
Jump to:
| Id | http://www.semanticweb.org/admin/ontologies/2022/7/MIO:01070
http://www.semanticweb.org/admin/ontologies/2022/7/MIO:01070
|
|---|---|
| Preferred Name | anti-diabetic agent |
| Definitions |
Any substance used to reduce hyperglycemia or treat disorders associated with diabetes. Based on their mechanism of action, this class of agents can be classified to the following groups: directly acting insulomimetics, which activates insulin receptors; indirectly acting insulinomimetics, which increase insulin release such as sulfonylureas or which potentiate the effect of insulin such as metformin; those act directly on the metabolism of glucose such as inhibitors of glucosidases and inhibitors of aldose reductase. [url:http://purl.obolibrary.org/obo/NCIT_C29711]
Diabetes leads to macrovascular complications such as MI and stroke and microvascular complications, principally ocular and renal. Nonetheless, MI and stroke are far and away the leading causes of death in patients with type 2 diabetes, and heart failure is also a major cause of their hospitalizations and
deaths.[url:https://pubmed.ncbi.nlm.nih.gov/30563358/]
|
| Synonyms |
antidiabetic drug
drug to treat diabetes
anti-diabetic agents
anti-diabetics
drugs to treat diabetes
antidiabetic agent
antidiabetic agents
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | Any substance used to reduce hyperglycemia or treat disorders associated with diabetes. Based on their mechanism of action, this class of agents can be classified to the following groups: directly acting insulomimetics, which activates insulin receptors; indirectly acting insulinomimetics, which increase insulin release such as sulfonylureas or which potentiate the effect of insulin such as metformin; those act directly on the metabolism of glucose such as inhibitors of glucosidases and inhibitors of aldose reductase. [url:http://purl.obolibrary.org/obo/NCIT_C29711] |
|---|---|
| label |
anti-diabetic agent
|
| comment |
Diabetes leads to macrovascular complications such as MI and stroke and microvascular complications, principally ocular and renal. Nonetheless, MI and stroke are far and away the leading causes of death in patients with type 2 diabetes, and heart failure is also a major cause of their hospitalizations and
deaths.[url:https://pubmed.ncbi.nlm.nih.gov/30563358/]
|
| prefLabel |
anti-diabetic agent
|
| reference |
PMID:30563358
NCIT:C29711
UMLS:C0935929
|
| synonyms |
antidiabetic drug
drug to treat diabetes
anti-diabetic agents
anti-diabetics
drugs to treat diabetes
antidiabetic agent
antidiabetic agents
See more
See less
|
| subClassOf | |
| type | |
| MIO_ID |
MIO:01070
|
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |